The AGA-glycan binding intensities were generally lower in HGSOC than in control or comparable in either group, which is fully consistent with previous studies including ours and indicates that cancer patients commonly had lower serum AGA levels [41, 60]: the exception to this is anti-GM1a IgM antibody, which is apparently elevated in HGSOC compared to controls. The gene discussed is AGA; the disease is cancer.